irsogladine has been researched along with Gastric Diseases in 2 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
| Excerpt | Relevance | Reference |
|---|---|---|
| "Irsogladine maleate (IM) has been used as a mucosal protective agent, whose action is partially explained as enhancement of mucosal blood flow, increase of cellular cyclic AMP and facilitation of gap-junctional intercellular communication." | 1.30 | Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats. ( Kashima, K; Katsura, M; Kodama, T; Okuma, S; Tanino, M; Tatsumi, Y, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, K | 1 |
| Irie, M | 1 |
| Tsuchiya, N | 1 |
| Yamauchi, E | 1 |
| Kawashima, M | 1 |
| Miyayama, T | 1 |
| Fukuda, H | 1 |
| Yamauchi, R | 1 |
| Umeda, K | 1 |
| Takata, K | 1 |
| Tanaka, T | 1 |
| Inomata, S | 1 |
| Morihara, D | 1 |
| Takeyama, Y | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Hirai, F | 1 |
| Tatsumi, Y | 1 |
| Tanino, M | 1 |
| Kodama, T | 1 |
| Kashima, K | 1 |
| Katsura, M | 1 |
| Okuma, S | 1 |
1 trial available for irsogladine and Gastric Diseases
| Article | Year |
|---|---|
Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.
Topics: Adult; Aged; Blotting, Western; Claudin-3; Edema; Female; Gastric Mucosa; Gene Expression; Humans; H | 2021 |
1 other study available for irsogladine and Gastric Diseases
| Article | Year |
|---|---|
Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Gastric Juice; Gastric Mucosa; Male; Phospholipids; Rats; Rats, | 1998 |